4Q2V image
Deposition Date 2014-04-10
Release Date 2015-04-15
Last Version Date 2023-11-08
Entry Detail
PDB ID:
4Q2V
Title:
Crystal Structure of Ricin A chain complexed with Baicalin inhibitor
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.24
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 41 21 2
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Ricin
Chain IDs:A
Chain Length:279
Number of Molecules:1
Biological Source:Ricinus communis
Ligand Molecules
Primary Citation
Baicalin inhibits the lethality of ricin in mice by inducing protein oligomerization.
J.Biol.Chem. 290 12899 12907 (2015)
PMID: 25847243 DOI: 10.1074/jbc.M114.632828

Abstact

Toxic ribosome-inactivating proteins abolish cell viability by inhibiting protein synthesis. Ricin, a member of these lethal proteins, is a potential bioterrorism agent. Despite the grave challenge posed by these toxins to public health, post-exposure treatment for intoxication caused by these agents currently is unavailable. In this study, we report the identification of baicalin extracted from Chinese herbal medicine as a compound capable of inhibiting the activity of ricin. More importantly, post-exposure treatment with baicalin significantly increased the survival of mice poisoned by ricin. We determined the mechanism of action of baicalin by solving the crystal structure of its complex with the A chain of ricin (RTA) at 2.2 Å resolution, which revealed that baicalin interacts with two RTA molecules at a novel binding site by hydrogen bond networks and electrostatic force interactions, suggesting its role as molecular glue of the RTA. Further biochemical and biophysical analyses validated the amino acids directly involved in binding the inhibitor, which is consistent with the hypothesis that baicalin exerts its inhibitory effects by inducing RTA to form oligomers in solution, a mechanism that is distinctly different from previously reported inhibitors. This work offers promising leads for the development of therapeutics against ricin and probably other ribosome-inactivating proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures